March 17th, 2017
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News.
Mayo Clinic researchers pinpoint experimental drug that may shrink tumors in multiple myeloma patients
by Jason Pope
The Mayo Clinic says this experimental drug is leading to tumor shrinkage in patients affected by multiple myeloma. Multiple myeloma is a cancer that affects the blood cells that fight infection. Rather than fighting infection, the cancer causes kidney problems and infections. According to Dr. Marta Chesi, the drug was developed to support tumor death but instead of killing the tumor cells, it made them more visible. This visibility helps the immune system spot the tumor cells and eliminate them.
Reach: KTTC is an NBC affiliate that serves the Rochester, Minn. area including the towns of Austin, Mason City, Albert Lea and Winona. Its website receives more than 73,300 unique visitors each month.
Additional coverage: Life Science Daily
Context: Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine. Multiple myeloma is a blood cancer that affects plasma cells – white blood cells that normally produce antibodies to fight infection. Rather than produce helpful antibodies, the cancer cells, as they grow, secrete large amounts of a single antibody that accumulate in the body, causing kidney problems and infections. More information can be found on Mayo Clinic News Network.
Contact: Julie Janovsky-Mason
Finding treatments to fight fibroids
Fibroid embolization and focused ultrasound are minimally invasive options that reproductive endocrinologist Dr. Ebbie Stewart says warrant more research to help guide women and health care providers on a treatment plan. She co-authored a recent study that looked at the two treatments, compared recovery time, and noted adverse events in the first six weeks after treatment, Dr. Stewart says.
Reach: The Huffington Post attracts over 38.7 million monthly unique viewers.
Context: Elizabeth "Ebbie Stewart, M.D. is a Mayo Clinic ObGyn. Dr. Stewart studies uterine fibroids, also called uterine leiomyomas or myomas. Fibroids are noncancerous tumors of the uterus that commonly cause heavy menstrual bleeding, pelvic pain and pressure, bowel and bladder problems, and sometimes infertility and miscarriage. Fibroids are also the leading cause of hysterectomy.
Contact: Kelley Luckstein
This Exact Workout Routine May Actually Reverse Aging
by Elizabeth Millard
Research has shown physical activity can reduce inflammation in your body and improve heart health—both important for staying young beyond your years. But not all exercise is the same in keeping age-related decline at bay, researchers from the Mayo Clinic say…“Decline is mitochondria is the key factor responsible for age-related physical declines,” says the study’s senior author, Sreekumaran Nair, M.D., Ph.D. That includes osteoporosis, arthritis, gastrointestinal issues, decreased flexibility, hypertension, and cardiovascular issues. “Higher intensity of exercise seems to elicit a rejuvenation of mitochondrial [processes] in everybody, including older people.”
Reach: Men's Health has an audience of more than 13.5 million readers.
Context: Everyone knows that exercise is good for you, but what type of training helps most, especially when you’re older - say over 65? A Mayo Clinic study says it’s high-intensity aerobic exercise, which can reverse some cellular aspects of aging. The findings appear in Cell Metabolism. Mayo researchers compared high-intensity interval training, resistance training and combined training. All training types improved lean body mass and insulin sensitivity, but only high-intensity and combined training improved aerobic capacity and mitochondrial function for skeletal muscle. Decline in mitochondrial content and function are common in older adults. More information can be found on Mayo Clinic News Network.
Contact: Bob Nellis
It’s not just being stuck inside; cold weather sets us up for getting sick
by Emily Sohn
It's not clear why winter brings so many health woes, says Pritish Tosh, an infectious-disease physician and researcher at the Mayo Clinic in Rochester, Minnesota. "The reason one virus is a wintertime virus may not be the same reason another virus is a wintertime virus," Tosh says. "We're finding more and more that it's not one size fits all."
Reach: Weekday circulation of The Washington Post is more than 356,000. The Post's website receives more than 32.7 million unique visitors each month.
Context: Pritish Tosh, M.D. is a Mayo Clinic infectious diseases specialist. Dr. Tosh is interested in emerging infections and preparedness activities related to them, ranging from collaborating with the Mayo Clinic Vaccine Research Group in basic science vaccine development to hospital systems research related to pandemic preparedness. Influenza is a viral infection that attacks your respiratory system — your nose, throat and lungs. Influenza, commonly called the flu, is not the same as stomach "flu" viruses that cause diarrhea and vomiting.
Contact: Bob Nellis
Page loaded in 0.432 seconds